Takeda Reports Better Version Of Prevacid Heartburn Drug
This article was originally published in PharmAsia News
Executive Summary
In a comparison with its best-selling drug Prevacid (lansoprazole), Takeda Pharmaceutical says its new version of the heartburn drug, TAK-390MR, has proven to be more effective. Takeda said a pair of Phase III trials of patients with erosive esophagitis showed the newer version to be better. The results are important to Takeda since Prevacid is set to lose patent protection in November of next year. Takeda hopes to introduce the new version by the end of this year. (Click here for more